Adimab
Developing therapeutic human antibodies using a yeast-based discovery platform.
H-1B sponsor history — This employer has had H-1B petitions approved by USCIS in the last five fiscal years, per the USCIS H-1B Employer Data Hub. The approval belongs to the employer and is not a commitment to sponsor this role.
BiotechnologyPharmaceuticals
Company facts
- Founded
- 2007
- Employees
- 139
- Headquarters
- United States
- Type
- Private
- Funding
- Series F · $13.8M · 2012